SmithRx is expanding the Connect 360 Autoimmune Program to include the Stelara biosimilars.

March 4 at 9 a.m. PT/ 12 p.m. ET | Connect Insiders Webinar

Alissa Johnson, Director of Clinical Strategy, will delve into the details of biosimilars, the exciting Connect 360 Autoimmune program updates, and answer your questions.

• Learn about biosimilars launching in 2025, including expanded clinical options for members with enhanced savings for employers.

• Get an early peek into the Connect 360 Autoimmune program updates, including Stelara biosimilars.

‍